Home / Health / Generic CF Drug Offers Hope at Fraction of Cost
Generic CF Drug Offers Hope at Fraction of Cost
7 Jan
Summary
- A generic cystic fibrosis drug will cost $2,000 annually, a 99.5% price reduction.
- The new treatment is produced by Bangladeshi company Beximco, available from Spring 2026.
- Patient advocacy groups drove the development of this affordable life-saving medication.

A significant reduction in the cost of cystic fibrosis medication is bringing renewed hope to patients worldwide. A Bangladeshi pharmaceutical company, Beximco, is set to release Triko, a generic version of a vital CFTR modulator drug, for an estimated annual cost of $2,000 for adults and $6,375 for children. This represents a dramatic 99.5% price decrease from the original patented treatment.
This advancement is largely attributed to persistent advocacy from patient groups, who have campaigned for years against the prohibitive pricing of essential cystic fibrosis therapies. The original drug, ETI (elexacaftor/tezacaftor/ivacaftor), was priced at $370,000 annually by Vertex Pharmaceuticals. The new generic version, Triko, is scheduled for availability from Spring 2026, following successful collaboration between advocacy groups like Just Treatment and Beximco.




